ATTENTION ALL ACADEMIC STAFF (AUSTRALIA ONLY) - ACADEMIC PROMOTION INFORMATION SESSION

Information sessions for fixed-term and continuing academic staff who are interested in applying for academic promotion have been scheduled for September.

• 21 September, 2:00 - 3:30 PM: Basic Research session
• 24 September, 1:00-2:30 PM: Clinical Research session

It is strongly encouraged that you attend a faculty information session if you are considering applying for promotion. More information about all the sessions, including the registration links, can be found here.  Kindly register your interest to attend the faculty information session by: Wednesday 16th September. 

Congratulations to Professor Peter Ebeling AO - newly appointed President-Elect of ASBMR

Congratulations to Professor Peter Ebeling AO, Head of the Department of Medicine in the School of Clinical Sciences at Monash Health, as he was recently announced President-Elect of the American Society for Bone and Mineral Research (ASBMR).

This is a massive milestone as Professor Peter Ebeling is the first President to be elected outside of North America.  

Read the full story HERE

Don’t pin all our hopes on a vaccine

 

Professor Eric Morand (Head of the School of Clinical sciences at Monash Health) and Dr Samar Ojaimi (Infectious Diseases Specialist at Monash Health) recently published an article in The Age on the importance of understanding and treating the clinical symptoms that come with COVID-19. 

Webinar: Addressing Achievement Relative to Opportunity 31 August

Date:               Monday 31 August 2020
Time:              2:00pm - 3:30pm
Presenters:     Professor Matthew Gillespie, Vice-Provost (Faculty and Graduate Affairs);
                        Professor Maria Garcia de la Banda, Deputy Dean (Research), Faculty of IT 

Please register here.

New Opportunity: MRFF Clinical Trials Activity Initiative - COVID-19

MRFF - Clinical Trials Activity Initiative - 2020 Rare Cancers, Rare Diseases and Unmet Need COVID-19 Grant

The objective of this Grant Opportunity is to utilise clinical trials to investigate effective mechanisms for the prevention or treatment of COVID-19 or its symptoms. Applications must propose a clinical trial that addresses a gap in current research and/or knowledge in with a specific focus on COVID-19.The intended outcome of this research is to deliver high quality evidence of strategies for the prevention or treatment of COVID-19 or its symptoms that can be translated into policy or practice.